Skip to content

A Natural Way to REVERSE
Artery Blockages? Is It Too Late for 80s?

IMPORTANT HEALTH UPDATE May take up to 10 seconds to load. Make sure your sound is on

Scientific References

The company is not endorsed by, sponsored by, or affiliated with any of these organizations

  • Martens, P., Nijst, P. & Mullens, W. Current approach to decongestive therapy in acute heart failure. Curr. Heart Fail. Rep. 12, 367–378 (2015).
  • Filippatos, G. et al. Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure. JAMA Cardiol. 5, 401–410 (2020).
  • Rubio-Gracia, J. et al. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int. J. Cardiol. 258, 185–191 (2018).
  • Gheorghiade, M. et al. Congestion is an important diagnostic and therapeutic target in heart failure. Rev. Cardiovasc. Med. 7 (Suppl. 1), S12–S24 (2006).
  • Ford E.S., Ajani U.A., Croft J.B., Critchley J.A., Labarthe D.R., Kottke T.E., Giles W.H., Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N. Engl. J. Med. 2007;356:2388–2398.
  • Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., de Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., et al. Executive summary: Heart disease and stroke statistics 2010 update: A report from the American Heart Association. Circulation. 2010;121:948–954.
  • Aggarwal A., Srivastava S., Velmurugan M. Newer perspectives of coronary artery disease in young. World J. Cardiol. 2016;8:728–734.
  • Writing Group Members. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., Das S.R., de Ferranti S., Despres J.P., et al. Heart disease and stroke statistics-2016 Update: A report from the American Heart Association. Circulation. 2016;133:e38.
  • Suri R.M., Antiel R.M., Burkhart H.M., Huebner M., Li Z., Eton D.T., Topilsky T., Sarano M.E., Schaff H.V. Quality of life after early mitral valve repair using conventional and robotic approaches. Ann. Thorac. Surg. 2012;93:761–769.
  • Kypson A.P. Recent trends in minimally invasive cardiac surgery. Cardiology. 2007;107:147–158. doi: 10.1159/000094736.
  • Bonaros N., Schachner T., Wiedemann D., Oehlinger A., Ruetzler E., Feuchtner G., Kolbitsch C., Velik-Salchner C., Friedrich G., Pachinger O., et al. Quality of life improvement after robotically assisted coronary artery bypass grafting. Cardiology. 2009;114:59–66.
  • Chorny M., Fishbein I., Yellen B.B., Alferiev I.S., Bakay M., Ganta S., Adamo R., Amiji M., Friedman G., Levy R.J. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc. Natl. Acad. Sci. USA. 2010;107:8346–8351.
  • Rhee J.W., Wu J.C. Advances in nanotechnology for the management of coronary artery disease. Trends Cardiovasc. Med. 2013;23:39–45.
  • Ceylan H., Tekinay A.B., Guler M.O. Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface. Biomaterials. 2011;32:8797–8805.
  • Boden WE, O’Rourke RA, Teo KT, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516.
  • Spertus JA, Jones PG, Maron DJ et al. Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med. 2020; 382: 1408-1419.
  • Nicholls SJ, Ballantyne CM, Barter PJ et al. Effect of two intensive statin regimens on conservative care in coronary disease. N Engl J Med. 2020; 382: 1408-1419.
  • Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366: 1267-1278.
  • Nakamura T, Obata JE, Kitta Y et al. Rapid stabilization of vulnerable carotid plaque within 1 month of Pitavastatin treatment in patients with acute coronary syndrome. J Cardiovasc Pharmacol. 2008; 51: 365-371.
  • Goff SL, Mazor KM, Ting HH, Kleppel R, Rothberg MB. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis. JAMA Intern Med. 2014; 174: 1614-1621.
  • Lin GA, Dudley RA, Redberg RF. Cardiologists’ use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007; 167: 1604-1609.
  • Schade DS, Eaton RP. A simplified approach to reducing cardiovascular risk. J Clin Endocrinol Metab. 2019; 104: 6033-6039.